logo

INMB

INmune Bio·NASDAQ
--
--(--)
--
--(--)

INMB fundamentals

INmune Bio (INMB) expects to report earnings on Mar 30, 2026, with estimated revenue of 0 (YoY --), and EPS at -0.26 (YoY +35.00%).
Revenue estimate / YoY
0
--
EPS estimate / YoY
-0.26
+35.00%
Report date
Mar 30, 2026
Earnings Call
4:30 PM on Mar 30, 2026
Meeting link.

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

INmune Bio (INMB) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

INmune Bio (INMB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

INmune Bio (INMB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

INmune Bio (INMB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does INmune Bio (INMB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track INmune Bio (INMB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield